Bleomycin (Amneal Biosciences)


Welcome to the PulseAid listing for the Bleomycin drug offered from Amneal Biosciences. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Amneal Biosciences
NON-PROPRIETARY NAME: Bleomycin
SUBSTANCE NAME: BLEOMYCIN SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
START MARKETING DATE: 2016-06-20
END MARKETING DATE: 0000-00-00


Bleomycin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBleomycin from Amneal Biosciences
LABELER NAME: Amneal Biosciences
DEA SCHEDULE:
ACTIVE STRENGTH: 15000([iU]/1)
START MARKETING DATE: 2016-06-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70121-1567_12921a48-db2b-4520-a2d6-1dacade3002e
PRODUCT NDC: 70121-1567
APPLICATION NUMBER:

Other BLEOMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal BiosciencesBleomycin
Fresenius Kabi USA, LLCBleomycin
Hospira, Inc.Bleomycin
Teva Parenteral Medicines, Inc.Bleomycin